Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level

Xianjing Hu
, Sarwat Fatima
, Minting Chen
, Tao Huang
, Yuen Wa Chen
, Ruihong Gong
, Hoi Leong Xavier Wong
, Rongmin Yu
, Liyan Song
, Hiu Yee Kwan^*
, Zhaoxiang Bian^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

13 Citations (Scopus)

Sort by:

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science